Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FRASU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,472
Award facts
- Contract value 100% obligated
- $3,471.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $3,471.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The contract is a firm fixed-price delivery order with an ultimate completion date of October 14, 2025, and was awarded on September 22, 2025. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its consistent delivery of branded and generic prescription drugs, biologics, over-the-counter medications, and specialized medical consumables to Department of Defense healthcare sites. The company's contract portfolio demonstrates its capability to supply diverse pharmaceutical products ranging from contraceptive devices to oncology treatments and vaccines. This delivery order requires no set-aside designation, reflecting the contractor's ability to compete effectively as a small business in the federal procurement marketplace while fulfilling essential medical supply requirements for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FRASU?
SPE2DB25FRASU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FRASU worth?
The government has obligated $3,472 on SPE2DB25FRASU.
Is contract SPE2DB25FRASU an order under another contract?
Yes. SPE2DB25FRASU is a delivery order under SPE2DB25D9308, an indefinite delivery contract.
Was contract SPE2DB25FRASU competed?
The extent of competition for SPE2DB25FRASU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award